Plus Therapeutics (PSTV) Provides Business Update on CNSide Diagnostics Subsidiary
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary
June 26, 2025 7:30 AM EDTU.S. commercial rollout of novel diagnostic platform to begin second half 2025
Underserved CNS cancer diagnostic U.S. market opportunity estimated to be in excess of $6 billion
Management to host a conference call today at 9am ET
HOUSTON, June 26, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc.... More



